• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肿瘤细胞衰老反应产生侵袭性变体。

Tumor cell senescence response produces aggressive variants.

作者信息

Yang Leixiang, Fang Jia, Chen Jiandong

机构信息

Molecular Oncology Department, H. Lee Moffitt Cancer Center, 12902 Magnolia Drive, Tampa, FL 33612, USA.

Tumor Biology Department, H. Lee Moffitt Cancer Center, 12902 Magnolia Drive, Tampa, FL, USA.

出版信息

Cell Death Discov. 2017 Aug 21;3:17049. doi: 10.1038/cddiscovery.2017.49. eCollection 2017.

DOI:10.1038/cddiscovery.2017.49
PMID:28845296
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5563524/
Abstract

Tumors often respond favorably to initial chemotherapy but eventually relapse with drug resistance and increased metastatic potential. Cellular senescence is a major therapeutic outcome of cancer chemotherapy, which leads to tumor stasis or regression through immune clearance of senescent cells. However, senescent tumor cells have been shown to resume proliferation at low frequency. We found that subjecting arrested senescent tumor cells to cytotoxic treatments stimulates the clonogenic proliferation of remaining survivors. The senescence revertants showed a reduced rate of proliferation but increased migration and invasion potential , and increased tumorigenic potential . Gene expression profiling showed that the senescence revertants are distinct from both parental and senescent cells. A subset of senescence-activated genes remains active in the revertants. These genes are implicated in regulating cell motility, invasion, and metastasis, which may collectively contribute to the aggressiveness of the revertants. The findings suggest that although therapy-induced senescence has short-term benefits, the response also causes reprogramming of gene expression and activates invasion-related genes that accelerate tumor progression.

摘要

肿瘤通常对初始化疗反应良好,但最终会因耐药性和转移潜能增加而复发。细胞衰老 是癌症化疗的主要治疗结果,它通过衰老细胞的免疫清除导致肿瘤停滞或消退。然而,已表明衰老肿瘤细胞会以低频率恢复增殖。我们发现,对停滞的衰老肿瘤细胞进行细胞毒性治疗会刺激剩余存活细胞的克隆增殖。衰老逆转细胞的增殖速率降低,但迁移和侵袭潜能增加,且致瘤潜能增加。基因表达谱分析表明,衰老逆转细胞与亲代细胞和衰老细胞均不同。一部分衰老激活基因在逆转细胞中仍保持活跃。这些基因与调节细胞运动、侵袭和转移有关,可能共同导致逆转细胞的侵袭性。这些发现表明,尽管治疗诱导的衰老有短期益处,但这种反应也会导致基因表达重编程并激活加速肿瘤进展的侵袭相关基因。

相似文献

1
Tumor cell senescence response produces aggressive variants.肿瘤细胞衰老反应产生侵袭性变体。
Cell Death Discov. 2017 Aug 21;3:17049. doi: 10.1038/cddiscovery.2017.49. eCollection 2017.
2
Senescence-associated IL-6 and IL-8 cytokines induce a self- and cross-reinforced senescence/inflammatory milieu strengthening tumorigenic capabilities in the MCF-7 breast cancer cell line.衰老相关的白细胞介素-6和白细胞介素-8细胞因子诱导一种自我和交叉强化的衰老/炎症环境,增强MCF-7乳腺癌细胞系的致瘤能力。
Cell Commun Signal. 2017 May 4;15(1):17. doi: 10.1186/s12964-017-0172-3.
3
Klotho-mediated targeting of CCL2 suppresses the induction of colorectal cancer progression by stromal cell senescent microenvironments.Klotho 介导的 CCL2 靶向抑制基质细胞衰老微环境诱导的结直肠癌进展。
Mol Oncol. 2019 Nov;13(11):2460-2475. doi: 10.1002/1878-0261.12577. Epub 2019 Oct 6.
4
Preclinical antitumor efficacy of senescence-inducing chemotherapy combined with a nanoSenolytic.诱导衰老化疗联合纳米 Senolytic 的临床前抗肿瘤疗效。
J Control Release. 2020 Jul 10;323:624-634. doi: 10.1016/j.jconrel.2020.04.045. Epub 2020 May 4.
5
Trabectedin modulates the senescence-associated secretory phenotype and promotes cell death in senescent tumor cells by targeting NF-κB.曲贝替定通过靶向核因子κB调节衰老相关分泌表型并促进衰老肿瘤细胞的死亡。
Oncotarget. 2018 Apr 13;9(28):19929-19944. doi: 10.18632/oncotarget.24961.
6
SASP-Dependent Interactions between Senescent Cells and Platelets Modulate Migration and Invasion of Cancer Cells.衰老相关分泌表型依赖的衰老细胞与血小板之间的相互作用调节癌细胞的迁移和侵袭。
Int J Mol Sci. 2019 Oct 24;20(21):5292. doi: 10.3390/ijms20215292.
7
Possibility of inducing tumor cell senescence during therapy.治疗期间诱导肿瘤细胞衰老的可能性。
Oncol Lett. 2021 Jul;22(1):496. doi: 10.3892/ol.2021.12757. Epub 2021 Apr 27.
8
Therapy-Induced Cellular Senescence Induces Epithelial-to-Mesenchymal Transition and Increases Invasiveness in Rectal Cancer.治疗诱导的细胞衰老诱导直肠癌中的上皮-间质转化并增加侵袭性。
Clin Colorectal Cancer. 2016 Jun;15(2):170-178.e3. doi: 10.1016/j.clcc.2015.09.003. Epub 2015 Oct 24.
9
Cancer-associated S100P protein binds and inactivates p53, permits therapy-induced senescence and supports chemoresistance.癌症相关的S100P蛋白结合并使p53失活,引发治疗诱导的衰老并增强化疗耐药性。
Oncotarget. 2016 Apr 19;7(16):22508-22. doi: 10.18632/oncotarget.7999.
10
Cellular Senescence Promotes Adverse Effects of Chemotherapy and Cancer Relapse.细胞衰老促进化疗的不良影响和癌症复发。
Cancer Discov. 2017 Feb;7(2):165-176. doi: 10.1158/2159-8290.CD-16-0241. Epub 2016 Dec 15.

引用本文的文献

1
A Dual-Payload Bispecific ADC Improved Potency and Efficacy over Single-Payload Bispecific ADCs.一种双payload双特异性ADC比单payload双特异性ADC具有更高的效力和疗效。
Pharmaceutics. 2025 Jul 25;17(8):967. doi: 10.3390/pharmaceutics17080967.
2
Talazoparib and radiation enhance the senolytic efficacy of venetoclax in therapy-induced senescent triple-negative breast cancer cells.他拉唑帕尼和放疗可增强维奈克拉对治疗诱导的衰老三阴性乳腺癌细胞的促衰老清除功效。
Saudi Pharm J. 2025 Aug 26;33(5):31. doi: 10.1007/s44446-025-00034-2.
3
Targeting Cellular Senescence with Liposome-Encapsulated Fisetin: Evidence of Senomorphic Effect.

本文引用的文献

1
Clearance of senescent cells by ABT263 rejuvenates aged hematopoietic stem cells in mice.ABT263清除衰老细胞可使小鼠体内衰老的造血干细胞恢复活力。
Nat Med. 2016 Jan;22(1):78-83. doi: 10.1038/nm.4010. Epub 2015 Dec 14.
2
Nucleolar repression facilitates initiation and maintenance of senescence.核仁抑制促进衰老的起始和维持。
Cell Cycle. 2015;14(22):3613-23. doi: 10.1080/15384101.2015.1100777.
3
Is Senescence Reversible?衰老可以逆转吗?
用脂质体包裹的漆黄素靶向细胞衰老:衰老形态效应的证据。
Int J Mol Sci. 2025 Aug 2;26(15):7489. doi: 10.3390/ijms26157489.
4
Exosomes Derived from Induced and Wharton's Jelly-Derived Mesenchymal Stem Cells Promote Senescence-like Features and Migration in Cancer Cells.源自诱导型和沃顿胶间充质干细胞的外泌体促进癌细胞的衰老样特征和迁移。
Int J Mol Sci. 2025 Jun 26;26(13):6178. doi: 10.3390/ijms26136178.
5
Anastasis and Other Apoptosis-Related Prosurvival Pathways Call for a Paradigm Shift in Oncology: Significance of Deintensification in Treating Solid Tumors.回生及其他与细胞凋亡相关的促生存途径呼唤肿瘤学范式转变:实体瘤治疗中减强度治疗的意义
Int J Mol Sci. 2025 Feb 22;26(5):1881. doi: 10.3390/ijms26051881.
6
Antioxidant Senotherapy by Natural Compounds: A Beneficial Partner in Cancer Treatment.天然化合物抗氧化衰老疗法:癌症治疗中的有益伙伴
Antioxidants (Basel). 2025 Feb 10;14(2):199. doi: 10.3390/antiox14020199.
7
Interplay between epigenetics, senescence and cellular redox metabolism in cancer and its therapeutic implications.癌症中表观遗传学、衰老与细胞氧化还原代谢之间的相互作用及其治疗意义。
Redox Biol. 2024 Dec;78:103441. doi: 10.1016/j.redox.2024.103441. Epub 2024 Nov 23.
8
Emerging insights in senescence: pathways from preclinical models to therapeutic innovations.衰老领域的新见解:从临床前模型到治疗创新的途径
NPJ Aging. 2024 Nov 22;10(1):53. doi: 10.1038/s41514-024-00181-1.
9
Amitotic Cell Division, Malignancy, and Resistance to Anticancer Agents: A Tribute to Drs. Walen and Rajaraman.无丝分裂细胞分裂、恶性肿瘤与抗癌药耐药性:献给瓦伦博士和拉贾拉曼博士
Cancers (Basel). 2024 Sep 8;16(17):3106. doi: 10.3390/cancers16173106.
10
Therapy-induced senescent tumor cells in cancer relapse.癌症复发中治疗诱导的衰老肿瘤细胞。
J Natl Cancer Cent. 2023 Sep 19;3(4):273-278. doi: 10.1016/j.jncc.2023.09.001. eCollection 2023 Dec.
Curr Drug Targets. 2016;17(4):460-6. doi: 10.2174/1389450116666150825113500.
4
Prodding the Beast: Assessing the Impact of Treatment-Induced Metastasis.刺激肿瘤:评估治疗诱导转移的影响。
Cancer Res. 2015 Sep 1;75(17):3427-35. doi: 10.1158/0008-5472.CAN-15-0308. Epub 2015 Jul 30.
5
Non-genetic cancer cell plasticity and therapy-induced stemness in tumour relapse: 'What does not kill me strengthens me'.肿瘤复发中的非遗传癌细胞可塑性与治疗诱导的干性:“杀不死我的,使我更强大”
Br J Cancer. 2015 May 26;112(11):1725-32. doi: 10.1038/bjc.2015.146. Epub 2015 May 12.
6
Senescent cells harbour features of the cancer epigenome.衰老细胞具有癌症表观基因组的特征。
Nat Cell Biol. 2013 Dec;15(12):1495-506. doi: 10.1038/ncb2879. Epub 2013 Nov 24.
7
Non-Darwinian dynamics in therapy-induced cancer drug resistance.治疗诱导的癌症药物耐药中的非达尔文动力学。
Nat Commun. 2013;4:2467. doi: 10.1038/ncomms3467.
8
Large-scale gene function analysis with the PANTHER classification system.大规模基因功能分析与 PANTHER 分类系统。
Nat Protoc. 2013 Aug;8(8):1551-66. doi: 10.1038/nprot.2013.092. Epub 2013 Jul 18.
9
Inhibition of RNA polymerase I as a therapeutic strategy to promote cancer-specific activation of p53.抑制 RNA 聚合酶 I 作为一种促进 p53 肿瘤特异性激活的治疗策略。
Cancer Cell. 2012 Jul 10;22(1):51-65. doi: 10.1016/j.ccr.2012.05.019.
10
shRNA targeting Bmi1 impedes the self-renewal of cisplatin-enriched stem-like cells in human A549 cells.shRNA 靶向 Bmi1 抑制人 A549 细胞中顺铂富集的干细胞样细胞的自我更新。
Oncol Rep. 2012 Aug;28(2):629-39. doi: 10.3892/or.2012.1843. Epub 2012 Jun 1.